Dexus AREIT Fund

Investment objectives

The primary investment return objectives of the Fund are to aim to provide:

• a gross annual income yield (before management fees and expenses) that is equivalent to at least 110% of the average yield of the S&P/ASX 300 AREIT Index Dividend Yield

• a level of capital growth which at least matches increases in CPI over a 5-7 year time horizon

• lower-than-market volatility compared with the S&P / ASX 300 AREIT Index over a 5-7 year time horizon

Benefits

• Focus on generating sustainable, regular and relatively high income returns through investing in listed property securities

• Access to an underlying diversified portfolio of thousands of quality commercial real estate assets predominantly located in Australia

• Has paid monthly distributions**

• Actively managed (non-index aware) portfolio, applying a highly disciplined and proven strategy designed to deliver on the Fund's income and risk objectives

• Currently liquid - daily applications and withdrawals (under normal market conditions, but withdrawals can take longer in certain cases as set out in the PDS) 

This fund is suited to

• Medium-to-long-term investors who are looking for an income-focused invstment and the potential for some long-term capital growth

• Investors wanting access to a diversified portfolio of AREITs primarily owning quality commercial real estate

Please refer to the Target Market Determination.

How to Invest

Allotment or issue of securities in the Dexus AREIT Fund will be made only on receipt of an application form attached to a copy of the Product Disclosure Statement (PDS), which has been lodged with the Australian Securities and Investments Commission. For more information on how to invest, click here.

To purchase units using the mFund Settlement Service (mFund code APF01), click here.

Apply Online

^{*Current running yield is calculated daily by dividing the annualised distribution rate by the latest entry unit price. Distributions may include a capital gains component. Distributions are not guaranteed and past performance is not an indication of future performance.}

^{**Past performance is not an indicator of future performance.}

^{***See section 6 of the PDS.}

^The Dexus AREIT Fund delivers lower risk compared to investing in the S&P/ASX 300 AREIT Index Dividend Yield.

^{This material has been prepared by Dexus Asset Management Limited (ACN 080 674 479, AFSL No. 237500) (“DXAM”), the responsible entity and issuer of the financial products of Dexus AREIT Fund (ARSN 134 361 229) without taking account of your objectives, financial situation and needs. Accordingly, and before you receive any financial service from us (including deciding to acquire or to continue to hold a product in any fund mentioned in this material), or act on this material, you should obtain and consider the relevant product disclosure statement(s) (“PDS”), DXAM financial services guide ("FSG”) and relevant target market determination (“TMD”) in full, consider the appropriateness of this material having regard to your own objectives, financial situation and needs and seek independent legal, tax and financial advice. The PDS, FSG and TMD (hard copy or electronic copy) are available from DXAM, Level 5, 80 Collins Street (South Tower), Melbourne VIC 3000, by visiting https://www.dexus.com/investor-centre, by emailing investorservices@dexus.com or by phoning 1800 996 456. The PDS contains important information about risks, costs and fees associated with an investment. Any investment is subject to investment risk, including possible delays in repayment and loss of income and principal invested, and there is no guarantee on the performance of the fund or the return of any capital. Past performance is not an indication of future performance. This material is for general information purposes only, (subject to applicable law) does not constitute financial product advice, and does not constitute an offer, invitation, solicitation or recommendation with respect to any investment. No warranty or representation is provided as to the accuracy, completeness or reliability of any information, and to the fullest extent permitted by law, the recipient releases DXAM and its affiliates from any and all liabilities and losses arising in connection with any person acting on or relying on anything contained in or omitted from this material (whether due to negligence or otherwise). This material is not intended for distribution or use in any jurisdiction where it would be contrary to applicable laws, regulations or directives.}